Skip to main content
  • Hub
  • News
  • Signals
  • Market
  • Economy
  • Country
  • Learn
  • Channel
  • Company
  • Livestream
  • Grafa TV
  • Quote
  • Forex
  • Assets
  • Quote
  • Settings
  • Asset
  • Signals
  1. Home
  2. quote
  3. Au Asx
  4. ocl

Latest news about ocl

Grafa
a month ago

Merck receives EC approval for ENFLONSIA™, a new long-acting shield against RSV in infants

Read more→
Grafa
a month ago

Invivyd upsizes Phase 3 trial capacity and targets 2026 for measles IND submission

Read more→
Grafa
2 months ago

Roivant pivot: FDA fast-tracks dermatomyositis drug as lead asset misses study goals

Read more→
Grafa
2 months ago

Immunovant shares tumble as batoclimab fails primary endpoint in pair of Phase 3 TED studies

Read more→
Grafa
2 months ago

Local Bounti reports 27% annual revenue growth and secures AI patent for growing tech

Read more→

Legal & info

  • T&Cs
  • Privacy Policy
  • Site Map
  • About

Get in touch

  • Contact
  • Support
  • Editorial
  • Advertising

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.

  • Asset
  • Signals
  • Hub
  • News
  • Signals
  • Market
  • Search